Close

Regeneron (REGN) Says EYLEA Clinically Equivalent to Lucentis Following VIEW 1, 2 Phase 3s

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/24/2024

1. TSLA
2. ENPH
3. TXN
4. SPOT
5. V
6. KMB
7. BA
8. FI
9. STX
10. GM


Go back to Regeneron (REGN) Says EYLEA Clinically Equivalent to Lucentis Following VIEW 1, 2 Phase 3s
Regeneron (NASDAQ: REGN) Delayed: 905.31 -2.01 (0.22%)
Previous Close $907.32    52 Week High $592.36 
Open $905.88    52 Week Low $325.35 
Day High $906.90    P/E 237.61 
Day Low $904.41    EPS $3.81 
Volume 21,968